Cyclic Peptide Phage-Hōʻike i ke kaʻina hana hōʻoia: He aha ka Cbl-b Haʻawina Hōʻike

Pane wikiwiki

How cyclization, sequence verification, lepili, ka maemae, and assay-ready material validate constrained cyclic peptide hits from Cbl-b phage display.

No ke aha he hihia ho'āʻo koʻikoʻi ʻo Cbl-b

Cbl-b (ʻO Casitas B-lāhui lymphoma-b) he E3 ubiquitin ligase e hoʻokiʻekiʻe i ka paepae hoʻāla o nā pūnaewele T a me nā pūnaewele NK., ka hana ʻana ma ke ʻano he intracellular immune checkpoint i hoʻohana ʻia e nā maʻi koko e kāohi i ka pale anti-tumor. As Ke kuhi nei iā Cbl-b i ka maʻi immunotherapy (2023) wehewehe, ʻO ka hana Cbl-b kiʻekiʻe e mālama i nā cell effector mai ka hoʻololi piha ʻana, ʻo ia ka mea e hoʻolilo ai i ka ligase i mea hoʻohana lāʻau lapaʻau maikaʻi akā maʻalahi.

ʻO ka paʻakikī kemika ʻo ka pilina pili o Cbl-b he protein-protein a me ka protein-phosphotyrosine contacts., ʻaʻole liʻiliʻi, nā ʻeke lāʻau lapaʻau o ke ʻano he peptide laina e hoʻopaʻa maʻalahi. ʻO kēia ke kūlana i loaʻa ai i nā peptides cyclic constrained ko lākou mālama: ʻO ka pani ʻana i kahi peptide i loko o kahi macrocycle e hoʻonohonoho mua iā ia i kahi ʻano hoʻopaʻa paʻa. ʻO ia ke kumu o ka phospho-pentapeptide Cblin (DGpYMP) a me ka phage i loaa mai CBLock, he mea hoʻopaneʻe peptide nanomolar o ka waihona CBL TKB, mea. Hōʻike lākou i kahi pahuhopu i manaʻo ʻia ʻaʻole hiki ke hoʻopaʻa ʻia e nā peptides maʻalahi hiki ke hana i ka wā i hoʻopaʻa ʻia ai kahi hoʻolālā paʻa a me kahi ala hōʻoia paʻa..

ʻO ka Discovery-to-Synthesis Workflow ma nā ʻanuʻu ʻeono

Hoʻokumu maikaʻi ʻia ka pipeline e hoʻopuka ai i kahi moho peptide cyclic constrained, a hoʻonohonoho ia i ke kahua no nā mea a pau e pono ai ke hōʻoia ʻana o ka synthesis lab. Kūkulu ʻia kahi waihona phage a hiki i ka 10¹¹–10¹² nā ʻano like ʻole i hiki ke hoʻohana ʻia nā peptides i hōʻike ʻia., a laila paʻi i ka Cbl-b i hoʻopaʻa ʻole ʻia i nā pōʻai he nui e hoʻonui i nā mea hoʻopaʻa. Hoʻopili ʻia nā mea hoʻokomo i hoʻonui ʻia e hoʻihoʻi hou i nā kumu ʻae, koho ʻia nā mea hoʻokani kiʻekiʻe, a ua hoʻohui hou ʻia kēlā mau kaʻina e like me ka discrete cyclic peptides - maʻamau e ka solid-phase peptide synthesis (SPSS) - ma mua o ka hoʻopaʻa ʻana i ka orthogonal a me ka hoʻāʻo hana.

As he cyclic peptide toolkit hōʻike (2024) hōʻike, ʻAʻole ka koho ʻana i ka hana hoʻoholo akā ʻo ka resynthesis a me ka hoʻomaʻemaʻe: ʻumikūmālua mau kaʻina waiwai i lawe ʻia i SPPS, a laila acidified, hoʻomaʻemaʻe ʻia e HPLC, a hōʻike ʻia ma mua o ka hilinaʻi ʻia ʻana o kekahi hoʻokolohua. Hoʻopaʻa ʻia kēlā ʻike hoʻokahi i ke kumu nui o nā pou hōʻoia ʻelima.

Hoʻolālā Kaʻikala: ʻO ka Geometry ka uku

ʻO ka hana olaola o kahi peptide i hoʻopaʻa ʻia e pili ana i ka hoʻolālā apo a me ke kemika pili, ʻaʻole wale ka amino acid linear sequence. ʻO kahi macrolactam poʻo a i ka huelo, he apo disulfide-stapled, he thioether-linked macrocycle, a i ʻole he scaffold CuAAC-cyclized kēlā me kēia hoʻokau ʻokoʻa ʻokoʻa ʻekolu-dimensional, a no laila he kūpono ʻokoʻa i ka ʻili i kuhi ʻia.

Pono ke kaohi i hoʻohana ʻia i ka pōʻai synthetic i ka mea i hōʻike ʻia e ka phage. ʻO ke ala ponoʻī o Nature e hoʻoikaika i ka manaʻo: pili kokoke, cyclization kikoʻī kahua (2024) a nā hale waihona puke cyclic peptide i hoʻopaʻa ʻia (2019) Hoʻomaopopo lāua ʻelua ʻo ke apo i hana ʻia ma ka ʻili phage ʻo ia ka conformation āu e makemake ai e hana hou mai ia mea.. Inā ʻokoʻa ke ala cyclization synthetic, ʻAʻole paha ʻo ka pūhui resynthesized ka mole i koho ʻia. ʻO kēia kahi o kahi hoa pili me ka ʻike hoʻolaʻa cyclic peptide synthesis - he loea e like me MOL Changes, nona ka hoʻopili ʻana i ka peptide cyclic maʻamau hiki ke hoʻohālikelike i ka palena i koho ʻia, mālama i nā kaʻina hydrophobic paʻakikī a me ka hoʻohuihui, a koho i ke ala pani apo pono, ʻo ia ke kumu o kahi paʻi hilinaʻi.

Hōʻoia Kaʻina: E hōʻoia ana i kāu mea i hana maoli ai

ʻO nā peptides cyclic kekahi o nā molekole paʻakikī e hoʻonohonoho. Me ka loaʻa ʻole o N- a i ʻole C-terminus, ʻAʻole hiki ke hoʻohaʻahaʻa Edman maʻamau, Pono ʻo NMR i nā mea ʻoi aku ma mua o ka pale maʻamau, a hoʻokaʻawale ka tandem mass spectrometry i ke apo ma nā wahi he nui, paʻakikī ka wehewehe ʻana. As he hoʻopaʻa haʻawina ʻike kikoʻī lehulehu (2011) wehewehe, ʻO ka hōʻoia ʻana i ke kaʻina i manaʻo ʻia a me ka topology no laila e koi i nā ala hoʻokaʻawale orthogonal - nā ʻano ring-cleavage, MS/MS nui-pae, a i ʻole nā ​​hoʻoheheʻe hoʻohui - no ka hoʻonohonoho pono ʻana i ka haku mele a me ka pilina.

ʻO ka hōʻoia sequence ka ʻokoʻa ma waena o kahi peptide e pili ana i ka ʻikepili hoʻonui a me ka mea e like me ia.. He hui hewa ʻole, ʻoki ʻia, a i ʻole nā ​​ʻano epimerized hiki ke lawe i ka hana i hōʻike ʻia e ka hoʻāʻo ʻana i lalo i ka pā i manaʻo ʻia. ʻO ka hōʻoia e pili ana i ka ʻike ʻelua (nuipa spec) a ʻo ka hōʻoia ʻana o ke kaʻina he puka hoʻokuʻu ʻole i hiki ke kūʻai ʻia ma mua o ka wehewehe ʻana.

Lepili Koho: He ʻano hoʻololi ka Tag, ʻAʻole he mea kōkua

Hoʻohuihui Peptide ʻO ka hapa nui o nā kaʻina hana hōʻoia pono e ʻike ʻia, a ʻo nā koho maʻamau ʻelua he biotin a me kahi fluorophore e like me FITC. Hiki i ka Biotin ke hoʻokuʻu ʻia ma luna o nā ʻili streptavidin no ka huki ʻana a me nā hoʻokūkū hoʻokūkū, ʻoiai ke kākoʻo nei ʻo FITC i ka polarization fluorescence a i ʻole nā ​​​​haʻawina uptake. Akā ʻaʻole kū ʻole ka lepili. Hiki ke hoʻololi i ka hoʻopaʻa ʻana i kahi hōʻailona nui, hikiwawe, hikiwawe, a me ka pili pono o kahi macrocycle liʻiliʻi, No laila, pono e hōʻike ʻia kahi analog i hoʻopaʻa ʻia e mālama i ka ʻano o ka peptide makua ma mua o ka hilinaʻi ʻana o kāna heluhelu ʻana.

He kumu maʻamau kēia o ka hilinaʻi hoʻopunipuni i ka hōʻoia ʻana: Hiki ke hōʻike i ka hopena o ka hōʻailona ma mua o ka hoʻopili pono ʻana i ka hoʻopaʻa inoa. ʻO ke koho ʻana i nā kemika kūpono - me ka lōʻihi o ka linker a me ka pūnaewele hoʻopili - a me ka hōʻoia ʻana i ka lepili e kūʻē i ka mana unlabeled he mea nui.. ʻO kahi kōpili hoʻololi a ka hoa synthesis, ka lōʻihi peptide biotinylation a ʻulaʻula (FITC, Cy) lepili, e hoʻohuli i kēia mai kahi piliwaiwai lima i hoʻokolohua hoʻomalu.

Helu Maemae: Hoʻokaʻawale i ka Paʻi mai kona mau hoalauna

ʻAʻole hāʻawi ka cyclic peptide synthesis i hoʻokahi ʻano. ʻAʻole i piha ka cyclization i nā laina mua, hoʻopuka ka oligomerization i nā dimer, a me ka isomerization a i ʻole epimerization e hoʻopuka i nā huahana pili akā ʻokoʻa - hiki ke hoʻololi i nā mea āpau i kahi heluhelu hoʻāʻo.. Mea hoʻomaʻemaʻe kiʻekiʻe, hoʻopaʻa ʻia e HPLC a kākoʻo ʻia e kahi moʻolelo haumia piha, e ho'ēmi i ka pilikia i loaʻa mai ka hana i ʻike ʻia mai kahi mea haumia ma mua o ka macrocycle i manaʻo ʻia.

No ka hoʻoholo ʻana i nā peptides screening-grade, ʻo kēia ka unuhi ʻana i kahi koi paʻa: koi i ka chromatogram, ʻaʻole wale ka pākēneka maʻemaʻe. ʻO ka maʻemaʻe HPLC ma luna o 95-98%, me ka ʻikepili MS a me nā palapala kikoʻī kikoʻī, 'O ia ka mea e 'ike ai ka hahai 'ana i ka hana a hiki ke hana hou 'ia ma nā pū'ulu. ʻAʻole ka hoʻomaʻemaʻe ʻana; ʻo ia ka ʻīpuka e mālama ai i kahi pōʻino maoli mai ka kanu ʻana i loko - a i hoʻonui ʻia e - kona mau hoalauna.

Mea Hoʻomakaukau Hoʻāʻo: ʻO ka Hōʻoiaʻiʻo ʻo Reproducibility

Hōʻike ka Phage enrichment hiki i kahi moho ke hoʻopaʻa i ka wā i hōʻike ʻia ma kahi ʻāpana virus; ʻAʻole ia e hōʻoia i ka hana ʻana o ka molekele resynthesized i kahi maʻemaʻe, hoʻohālikelike ʻia. ʻO nā mea hoʻomākaukau hoʻāʻo ʻo ia ka hiki ʻana o ka pūhui i ka nui kūpono, ma ke ano paakai pololei, me ka ʻole o nā counterions interfering a me endotoxin, a me ka lawa o nā palapala e hiki ai i kahi lab hou ke hana hou i ka hopena me ka ʻole o ka hoʻonui hou ʻana i ka kemika.

ʻO kēia kahi e lilo ai ka pūʻolo analytical i kumu hoʻokuʻu ma mua o ka noʻonoʻo hope. Endotoxin, kaumaha olaola, pH, mākū, mea kūʻē, a ʻo sterility nā ʻano e hoʻoholo ai i ka hana like ʻana o kahi peptide i ka Pōʻalima e like me ka hana ʻana ma ka Pōʻakahi - a inā paha e paʻa ka hopena i kahi papahana hoʻoponopono.. Hana ʻia ma lalo o a Papa 100 kaiapuni hoʻomalu maikaʻi me ka traceability puʻupuʻu piha, Hoʻololi nā mea hoʻomaʻamaʻa hoʻāʻo i kahi kaʻina hoʻohiki i kahi pale, kikoʻikepili hiki ke hana hou.

He papa inoa hōʻoia no nā Peptide Hits

  • E hōʻoia i ke ala cyclization synthetic e pili ana i ke kaohi i koho ʻia ma ka ʻili phage.
  • E hōʻoia i ka ʻike a me ke kaʻina me ka orthogonal mass spectrometry, ʻaʻole hoʻokahi waiwai nui.
  • E hōʻoia i kekahi lepili biotin a i ʻole fluorophore e kūʻē i ka ʻO nā Peptides Synthetic mana lepa ʻole ma mua o ka hilinaʻi ʻana i ka heluhelu ʻana.
  • E koi i ka maʻemaʻe o ka HPLC a me kahi ʻaoʻao haumia piha, me ka ʻikepili MS e pili pū ana. Hana ʻia ʻo Peptide
  • Koi i ka ʻikepili hoʻokuʻu mākaukau hoʻāʻo: kūʻē, endotoxin, kaumaha olaola, pH, a me ka sterility.
  • E hōʻoia i ka nui-a-lot reproducibility ma mua o ka hoʻonui ʻia ʻana mai ka nānā ʻana i ka hoʻonui alakaʻi.

Ki Takeaway: Ua lilo ka phage-display hit i alakaʻi wale nō ma hope o ka synthesis a me ka hōʻike ʻana i hōʻike ʻia i ka cyclic peptide resynthesized i hoʻololi pololei ʻia., kaʻina-hōʻoia, hōʻailona maʻemaʻe, maʻemaʻe kiʻekiʻe, a hiki ke hana hou. ʻO kēlā me kēia pou ʻelima he ʻīpuka kūʻokoʻa e mālama ana i nā mea waiwai mai ka pipeline ʻike lāʻau.

ʻO nā palena o kēia Lens hōʻoia

ʻElua mau hōʻailona e mālama pono i kēia anga. Ka mua, ʻAʻohe pepa Cbl-b cyclic peptide phage-display pepa i nānā ʻia e nā hoa i kēia manawa i kahi kaʻina piha., ʻikepili paʻa, a me ka mīkini ma kahi hoʻokahi; ʻO ke kaʻina hana ma luna nei ke ʻano maʻamau e hahai ai kēlā ʻano haʻawina a me ka hana peptide Cbl-b pili. (Cblin, CBLock) ua laʻana. Ka lua, ʻO ka hōʻoia ʻana o kahi hōʻailona maikaʻi i ka hoʻopaʻa ʻana ʻaʻole i wānana i ka pono therapeutic - ʻo ka Cbl-b inhibition in vivo lawe i ka pilikia autoimmunity maoli., no laila, pono e hōʻike ʻia ka pili pono hana ma ke kelepona a, hope loa, ʻO nā kumu hoʻohālike holoholona ma mua o ke alakaʻi i manaʻo ʻia he lāʻau lapaʻau.

Nā ʻanuʻu aʻe

Hoʻoholo ʻia ka ʻokoʻa ma waena o kahi pale maikaʻi a me kahi moho lāʻau maikaʻi mai ka phage, i loko o ka kemika a me ka hoʻohālikelike e hoʻohuli i kahi kaʻina i hōʻoia ʻia, molekele mākaukau hoʻāʻo. Inā ʻoe e neʻe nei i ka cyclic peptide paʻa ma o ka synthesis a me ka hōʻoia, Hiki i kahi hoa peptide akamai ke pani i kēlā āpau - e kamaʻilio me ka hui ʻenehana e pili ana i kāu hoʻonohonoho ʻana a loaʻa i kahi loiloi kūpono ma mua o kou hoʻokō ʻana i kāu kālā screening..

Bingyan Gao

Bingyan Gao

Mea Hana Pono a me Analytical Kaʻike kumu: ʻO ka hoʻokaʻawale ʻana a me ka ʻike ʻana i nā ʻano haumia, Hoʻomohala ʻano hana HPLC/MS, ka hoʻomaʻemaʻe kiral, a me ka hoʻokō ʻana i nā pharmacopoeias honua.

Pilikino: ʻO Bingyan Gao ka "puka kiaʻi hope" o ka maʻemaʻe peptide a me ka maikaʻi. Maikaʻi ʻo ia i ka hoʻohana ʻana i nā mea analytical kiʻekiʻe kiʻekiʻe a loea i ka hoʻomohala ʻana i nā ʻano hoʻokaʻawale chromatographic maʻamau no nā peptides hoʻololi paʻakikī.. Ua hoʻokumu ʻo ia i kahi ʻōnaehana hoʻomaʻemaʻe pono ʻole e hōʻoia i ka maʻemaʻe o ka huahana 99% a i ʻole kiʻekiʻe aʻe akā ʻike pono a hoʻopau i nā ʻano haumia i hiki ke hoʻoulu i ka immunogenicity. Me ka hoʻomaopopo hohonu ʻana i nā koi hoʻoponopono FDA a me EMA no nā lāʻau peptide, hōʻoia ʻo ia ʻo kēlā me kēia pūʻulu i hoʻokuʻu ʻia mai ka hale hana e hele pū ʻia me kahi palapala hōʻoia o ka ʻike ʻana (COA).

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana